Viewing StudyNCT06540352



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06540352
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-01

Brief Title: A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon Tablets 1 mg for Long-term Use to Prevent Recurrence of Atrial FibrillationFlutter After Terminating Its Persistent Form
Sponsor: None
Organization: None

Key Dates - Follows AllAPIJSON File Order

Start Date: None
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: None
Completion Date Type: None
First Submit Date: 2024-08-01
First Submit QC Date: None
Study First Post Date: None
Study First Post Date Type: None
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-20
Last Update Post Date: None
Last Update Post Date Type: None